430.2Cardiovascular Magnetic Resonance-Guided Rejection Surveillance in Cardiac Transplantation: Five-year Safety Outcomes
Yiling Situ (AU)
Long-term outcomes and precision surveillance in heart transplantation: Rejection, vasculopathy, and immune monitoring
Chairs
Kavitha Muthiah (AU)
· Lori J. West (CA)
Presentations
Oral Presentation
430.3The role of blood plasma cytokines in the diagnosis of rejection long-term after heart transplantation
Maria Simonenko (RU)
430.4Progression of cardiac allograft vasculopathy in heart recipients with donor-transmitted coronary atherosclerosis
Stepan Sakhovsky (RU)
Mini-Oral Presentation
430.5Evaluation of the coronary arteries of a heart transplant using optical coherence tomography
Stepan Sakhovsky (RU)
430.6HLA mismatch burden and De Novo malignancy after heart transplantation: A single-center Korean cohort study
Darae Kim (KR)
Rapid-Fire Presentation
430.8Genetic testing yield in heart transplant recipients with an undifferentiated cardiomyopathy – a single centre experience in Western Australia
Ellen McGuckin (AU)
430.9Long Term Survival and Graft Related Outcomes After Percutaneous Coronary Intervention for Cardiac Allograft Vasculopathy in Contemporary Australian Heart Transplant Recipients
Ajay Dharan (AU)